Add to Google




http://www.wikio.com

BLN RSS

Twitter



Alternative News,
Information, and Analysis

Rogue Government
What Really Happened
Cryptogon
Raw Story
Citizens for Legit Gov.
Information Clearing House
American Free Press
Global Research
The Peoples Voice
Tom Burghardt
Uncover The News
All Gov.
Media Monarchy
Information Liberation
TPM Muckraker
F. William Engdahl
Cryptome
Narco News
Media Matters
Uruknet
Corbett Report
Common Dreams
Alternet
Antiwar
Aftermath News
Steve Quayle
Wayne Madsen
Truth Out
Etherzone
Online Journal
Lew Rockwell
Dissident Voice
News With Views
Jeff Rense
Strike The Root
Peter Chamberlin
Dprogram
12160
Old Thinker News
Common Dreams
Empire Burlesque
American Exile
CNS News
IntelliBreifs
Electric Politics
Stop The Lie
Amy de Miceli
Crooks and Liars
Rumor Mill News
The Resident
Aangirfan
OpEDNews
The Brad Blog
Conspiracy Archive
Foreign Policy Journal
Counter Punch
August Review
Buzzflash
Truth Is Treason
NewsWires
News Now
My Way News
Reuters Alert Net
1st Headlines
Yahoo News
Ananova
Excite AP
Knight Ridder
Newsday AP
Google News
Swiss Info
ABC Wire
News Interactive
US Newswire
World News Network
United Press Int.
Associated Press
Excite News
MSN News
PR Newswire
Reuters
Scripps Howard
Xinhua
ZD Net
Online Only
Natural News
Real News Network
VOA News
Huffington Post
World Net Daily
Drudge Report
Newsmax
Boing Boing
Short News
Small Government Times
Capitol Hill Blue
Global Post
Business / Economics
Seeking Alpha
Market Watch
Bloomberg
Wall Street Journal
RTT News
CNN Money
Forbes
Business Week
Funny Money Report
Market Oracle
Money Morning
The Street
Shadow Stats
Economist
Financial Times
Fortune Magazine
Kitco
Gold Eagle
Max Keiser
321 Gold
Stock Charts
Zero Hedge
Washingtons's Blog
The Daily Reckoning
Energy Business Review
Milplex / Intel / Defense
Danger Room
Washington Technology
Defense Industry Daily
Global Security
Geopolitical Monitor
Defense Link
Stratfor
Space War
Jane's
Defense Tech
Strategy Page
Military Info Tech
Major US Newspapers
New York Times
New York Post
New York Daily News
Washington Post
Washington Times
L.A. Times
USA Today
Science / Tech News
Wired
Blast Magazine
PHYSorg
Science Daily
Popular Science
Engadget
New Scientist
Technovelgy
Singularity Hub
H+ Magazine
Science Magazine
Seed Magazine
CBR Online
Science News
SlashDot
Scientific American
Spectrum IEEE
Technology Review
io9
ZD Net
Technology News
The Register
Tech News World
VNU Net
Satire & Animation
Onion YouTube
Reptile God
Wahoos Mopar Grave Yard
Royal Canadian Air Farce
The Daily Show
The Colbert Report
Mark Fiore
All Hat No Cattle
Mack White
Propaganda Remix Project
Internet Weekly Report
Kontraband
Holy Lemon


oracle broadcasting









AddThis Feed Button
FKN NEWZ Texas Team Speak
Add to Technorati Favorites
Valid XHTML 1.0 Transitional






Police State

ADHD treatment causes young boys to develop female breasts
Published on 05-27-2009Email To Friend    Print Version
AddThis Social Bookmark Button

Source: 3news.co.nz

A drug used to treat ADHD children is causing concern in the United States.

It is called Risperdal and it is supposed to be used primarily for adults with sever psychological problems.

But last year it was prescribed more than 6.5 million times.

The side effects include young males developing female sex organs.

Nineteen-year-old John was just seven when he began taking Risperdal for ADD.

Even though the FDA approved the drug only for adult patients who were psychotic, John’s doctor and others widely prescribed it to kids for less severe behaviour problems.

Once taking Risperdal, John’s mum says he became aggressive, sleepy, and developed bowel problems. But the biggest shock came when he was 14 and started developing women’s breasts.

“He asked me if he was a girl,” she says.

It turns out Risperdal can increase production of a hormone called prolactin, which stimulates breast growth. It is called gynecomastia – and it is irreversible.

Risperdal and other so-called “atypical anti-psychotics” have exploded in use.

Hundreds of thousands of kids have been prescribed Risperdal in the 14 years it has been on sale – long before the FDA approved it for very limited pediatric use in 2006.

John and most of the other children were not psychotic at all, but were given Risperdal for behaviour disorders including autism and ADD.

Attorney Stephen Sheller is suing Janssen, which makes Risperdal. He claims Janssen marketed Risperdal for unapproved uses in children, downplayed serious risks like diabetes and seizures.

Janssen would not agree to an interview but told us the breast growth risk is “clearly stated in the FDA-approved” labelling, and “we only promote our products for their FDA-approved indications.”

Nobody knows how often it happens. But in Janssen’s own clinical trials with fewer than 2,000 children (1,885), 43 developed the abnormal breasts.

Mr Sheller represents John and nine other boys – one of whom was only four when he developed a breast on one side and began producing milk.

The treatment for the unbridled breast growth is as unthinkable as the disorder: painful removal of the breasts.
Eventually, the boys can appear normal again.

The family’s lawsuit is still in court.

But John’s mother says surgery did not fix all of the problems from the medicine.

When asked if John still thinks he’s a girl his mother wells up and cries before answering, “yes.”

As for Risperdal – it’s still on the market.  And families say putting even more children at risk.